Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||||
|
1.000 | 0.040 | 5 | 175445201 | upstream gene variant | G/C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.080 | 5 | 175445317 | upstream gene variant | A/G | snv | 5.2E-02 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 5 | 175445317 | upstream gene variant | A/G | snv | 5.2E-02 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 5 | 175441837 | synonymous variant | T/A;C | snv | 0.99 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 5 | 175442902 | synonymous variant | C/T | snv | 8.2E-03 | 2.1E-03 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.925 | 0.080 | 5 | 175443899 | 5 prime UTR variant | A/G;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | < 0.001 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.080 | 5 | 175443899 | 5 prime UTR variant | A/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.925 | 0.080 | 5 | 175443899 | 5 prime UTR variant | A/G;T | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | < 0.001 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.827 | 0.160 | 5 | 175443147 | 5 prime UTR variant | C/T | snv | 0.68 | 0.72 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.851 | 0.160 | 5 | 175443193 | 5 prime UTR variant | C/T | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.160 | 5 | 175443193 | 5 prime UTR variant | C/T | snv | 0.15 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.160 | 5 | 175443193 | 5 prime UTR variant | C/T | snv | 0.15 |
|
Behavior and Behavior Mechanisms | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.160 | 5 | 175443193 | 5 prime UTR variant | C/T | snv | 0.15 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.160 | 5 | 175443193 | 5 prime UTR variant | C/T | snv | 0.15 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.160 | 5 | 175443193 | 5 prime UTR variant | C/T | snv | 0.15 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.080 | 5 | 175441697 | 3 prime UTR variant | G/A;C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.807 | 0.080 | 5 | 175441697 | 3 prime UTR variant | G/A;C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.807 | 0.080 | 5 | 175441697 | 3 prime UTR variant | G/A;C;T | snv |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.807 | 0.080 | 5 | 175441697 | 3 prime UTR variant | G/A;C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2008 | 2008 |